Association of Hypometilating Agents (HMA) + Venetoclax (VEN) in the Treatment of Myeloproliferative Neoplasms in Blastic Phase (MPN-BP) and Acute Leukemias Evolved from Myelodysplastic Syndromes (AML-MDS) Already Treated with Azacytidine
Latagliata, Roberto, Cristiano, Gianluca, Lama, Dorela, Fenu, Susanna, Rizzo, Lorenzo, Cambò, Benedetta, Zoletto, Simone, Spirito, Francesca, Cavalca, Fabrizio, Cattaneo, Daniele, Cenfra, Natalia, De Luca, Giulia, Esposito Vangone, Beatrice, Di Veroli, Ambra, Palmieri, Raffaele, Annunziata, Mario, Mulas, Olga, Abruzzese, Elisabetta, Molteni, Alfredo, Piedimonte, Monica, Carmosino, Ida, Salutari, Prassede, Biagi, Annalisa, Bocchia, Monica, Santopietro, Michelina, Binotto, Gianni, Iurlo, Alessandra, Crugnola, Monica, Riva, Marta, Piccioni, Anna Lina, Elli, Elena Maria, Curti, Antonio, Poloni, Antonella
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article